The future of Pharmac is on the table in trade talks with the US, where big pharmaceutical companies are pushing for changes.
Pharmac used to be as popular as vermin. Think back to Herceptin and the cancer-stricken women who protested against Pharmac for denying them subsidised year-long courses of the drug and perhaps another chance at life.
Back then, Pharmac was treating New Zealand women like “lab rats”, according to the Breast Cancer Aotearoa Coalition. It was offering treatment that was “unproven, unsafe and cheap”, said National MP Dr Jackie Blue, a specialist in the area of breast cancer, by funding a nine-week but not a 12-month course of Herceptin. It was subjecting New Zealand women to what might ...
NZ Listener digital and print subscriptions
Thanks for your interest in this article. To get your latest edition of the NZ Listener via a print subscription click here.
The NZ Listener is now also available via a Zinio digital experience – read the latest edition on your computer or via the Zinio app on your tablet. To find our more click here.
Accessing archive content: If you’re interested in accessing archive content, please contact our NZ Listener helpdesk contact us. We endeavor to get back to you within 5 working days.
If you already have an archive content login, please login to view and unlock content.
Any queries regarding access please contact our NZ Listener helpdesk contact us.